Head: Dr Hayley Whitaker
The UCL Centre for Molecular Intervention (COMET) acts as a translational bridge between the basic lab science and clinical practice. COMET aims to develop molecular markers for diagnosis, prognosis and prediction of diseases, in particular cancer. We also aim to elucidate the molecular mechanisms behind novel biomarkers thus promoting their development as targeted therapeutics. The Centre uses state of the art genomic tools alongside automated histology, molecular biology and biochemical techniques.
- Understand the function and mechanism of action in cancer cells.
- Identify, validate and develop novel biomarker pipelines.
- Prioritise exciting targets for development of therapeutics for cancer.